{"paper_id": "c82cbad0be72eb11f029c28f3086d872a84146df", "metadata": {"title": "Chapter 8 Real-Time RT-PCR Detection of Equine Coronavirus", "authors": [{"first": "Fabien", "middle": [], "last": "Miszczak", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Nathalie", "middle": [], "last": "Kin", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Vincent", "middle": [], "last": "Tesson", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Astrid", "middle": [], "last": "Vabret", "suffix": "", "affiliation": {}, "email": ""}]}, "abstract": [{"text": "Equine coronavirus (ECoV) is a recently identifi ed equine virus, involved mainly in enteric infections. Since the ECoV discovery in 1999, only two real-time RT-PCRs have been developed for viral identifi cation. In this chapter we describe a one-step real-time RT-PCR that has been routinely used in our laboratory for ECoV detection from fecal and respiratory samples.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}], "body_text": [{"text": "Equine coronavirus (ECoV) is a Betacoronavirus-1 in the lineage A (betacoronavirus A1) that was identifi ed at the end of the last century [ 1 ] . ECoV belongs to the genus Betacoronavirus and is closely related to human coronavirus OC43 (HCoV-OC43), bovine coronavirus (BCoV), canine respiratory coronavirus (CRCoV), bubaline coronavirus (BuCoV), and porcine hemagglutinating encephalomyelitis virus (PHEV). ECoV was fi rst isolated in North Carolina, USA, from the feces of a diarrheic foal in 1999 (ECoV-NC99) [ 2 ] . Multiple ECoV outbreaks have recently been reported in Japan [ 3 , 4 ] and in the USA [ 5 ] . Major clinical signs observed were anorexia, fever, lethargy, leukopenia, and diarrhea, and unspecifi c discrete symptoms that do not lend to rapid diagnosis . ECoV was mainly detected in fecal samples from horses and less frequently in respiratory secretions [ 5 -7 ] . A small number of animals with signs of encephalopathic disease have also been observed during these outbreaks [ 8 ] .", "cite_spans": [{"start": 139, "end": 144, "text": "[ 1 ]", "ref_id": "BIBREF0"}, {"start": 513, "end": 518, "text": "[ 2 ]", "ref_id": "BIBREF1"}, {"start": 582, "end": 591, "text": "[ 3 , 4 ]", "ref_id": null}, {"start": 607, "end": 612, "text": "[ 5 ]", "ref_id": "BIBREF4"}, {"start": 875, "end": 883, "text": "[ 5 -7 ]", "ref_id": null}, {"start": 997, "end": 1002, "text": "[ 8 ]", "ref_id": "BIBREF7"}], "ref_spans": [], "section": "Introduction"}, {"text": "The current diagnosis of ECoV infection can be performed using virus isolation, electron microscopy, serology [ 9 ] . A reverse transcription loop-mediated isothermal amplifi cation (RT-LAMP), a non-PCR -based nucleic acid amplifi cation assay, has been recently developed for the detection of ECoV in fecal samples [ 10 ] . ECoV was also identifi ed by molecular methods in feces and respiratory samples of foals with and without enteric disease [ 2 , 11 , 12 ] . Real-time RT-PCR assays can enable a prompt identifi cation of ECoV in respiratory and fecal samples of horses who were at the early stage of disease onset [ 5 , 6 ] 10. Loading block (Qiagen \u00ae ).", "cite_spans": [{"start": 110, "end": 115, "text": "[ 9 ]", "ref_id": "BIBREF8"}, {"start": 316, "end": 322, "text": "[ 10 ]", "ref_id": "BIBREF9"}, {"start": 447, "end": 462, "text": "[ 2 , 11 , 12 ]", "ref_id": null}, {"start": 621, "end": 630, "text": "[ 5 , 6 ]", "ref_id": null}], "ref_spans": [], "section": "Introduction"}, {"text": "11. Rotor-Gene Q \u00ae real-time PCR machine (Qiagen \u00ae ) ( see Note 4 ).", "cite_spans": [], "ref_spans": [], "section": "RNA Extraction"}, {"text": "The protocol described below is routinely used for ECoV clinical diagnosis in fecal and respiratory samples. Two PCR assays are developed in our laboratory targeting partial M and N genes of the ECoV genome [ 6 ] . They were based on short RNA sequences deduced from the ECoV-NC99 strain [ 13 ] . The protocol described is based on the highest sensitive PCR targeting the M gene and proved to be a sensitive and useful tool for ECoV detection in fi eld samples ( see Note 5 ).", "cite_spans": [{"start": 207, "end": 212, "text": "[ 6 ]", "ref_id": "BIBREF5"}, {"start": 288, "end": 294, "text": "[ 13 ]", "ref_id": "BIBREF12"}], "ref_spans": [], "section": "Methods"}, {"text": "1. Transfer 10-50 % of fecal sample into a 2 ml sterile microcentrifuge tube and adjust to 1 ml with autoclaved 1\u00d7 PBS buffer.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "2. Centrifuge at 3,000 rpm (850 \u00d7 g ) for 30 min at room temperature.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "3. Transfer supernatant into a new 1.5 ml sterile microcentrifuge tube.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "4. Centrifuge at 10,000 rpm (9,400 \u00d7 g ) for 15 min at room temperature.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "5. Collect supernatant and store at +4 \u00b0C until RNA extraction.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "Respiratory samples (nasopharyngeal swabs) too mucous to be directly extracted with the QIAsymphony \u00ae SP automated instrument are previously treated by proteinase K.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "1. Add 10 % of proteinase K to the fi nal volume of respiratory specimen in a sterile 2 ml tube.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "2. Briefl y vortex tubes and incubate at 56 \u00b0C for 15 min.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "3. Store at +4 \u00b0C until RNA extraction. 4. Load the required elution rack into the \"Eluate\" drawer, and load the required reagent cartridge(s) and consumables into the \"Reagents and Consumables\" drawer.", "cite_spans": [], "ref_spans": [], "section": "Methods"}, {"text": "Place the samples into the appropriate sample carrier and the tubes containing the carrier RNA-Buffer AVE mixture into the tube carrier.", "cite_spans": [], "ref_spans": [], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "6. Enter the required information for each batch of samples to be processed:", "cite_spans": [], "ref_spans": [], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "(a) Sample information.", "cite_spans": [], "ref_spans": [], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "(b) Protocol to be run (\"complex200_V6_DSP\").", "cite_spans": [], "ref_spans": [], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "(c) Elution volume (60 \u03bcl) and output position.", "cite_spans": [], "ref_spans": [], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "(d) Tubes containing the carrier RNA-Buffer AVE mixture.", "cite_spans": [], "ref_spans": [], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "7. Run the purifi cation procedure.", "cite_spans": [], "ref_spans": [], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "8. After the RNA purifi cation, store the purifi ed RNA at 2-8 \u00b0C during 24 h before the one-step real-time RT-PCR . For longterm storage of over 24 h, store purifi ed RNA at -20 or -80 \u00b0C.", "cite_spans": [], "ref_spans": [], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "1. Prepare a one-step RT-PCR master mix suffi cient for the designated number of samples in a sterile 1.5 ml microcentrifuge tube on ice, according to Table 2 . Include at least one negative control (autoclaved RNase-free water) and one positive control ( see Note 6 ) for each run. Add additional controls (e.g., purifi ed RNA from the studied samples) as necessary.", "cite_spans": [], "ref_spans": [{"start": 151, "end": 158, "text": "Table 2", "ref_id": "TABREF3"}], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "2. Insert the strip tubes on the loading block. Aliquot 20 \u03bcl of the master mix into separate 0.1 ml strip tubes and label the tubes accordingly.", "cite_spans": [], "ref_spans": [], "section": "Perform an inventory scan of the \"Reagents and Consumables\" drawer."}, {"text": "3. Add 5 \u03bcl of each sample and positive control to these tubes. For the negative control, add 5 \u03bcl of autoclaved RNase-free water.", "cite_spans": [], "ref_spans": [], "section": "Real-Time RT-PCR Assay"}, {"text": "4. Close the strip tubes with caps. Insert the strip tubes into the 72-well rotor and lock the rotor into place on the rotor hub of the Rotor-Gene Q \u00ae PCR machine.", "cite_spans": [], "ref_spans": [], "section": "Real-Time RT-PCR Assay"}, {"text": "5. Turn on the real-time PCR machine (Rotor-Gene Q \u00ae ). Open the \"Rotor-Gene Q \u00ae series software\".", "cite_spans": [], "ref_spans": [], "section": "Real-Time RT-PCR Assay"}, {"text": "6. Check the \"Locking Ring Attached\" checkbox and then click \"Next\".", "cite_spans": [], "ref_spans": [], "section": "Real-Time RT-PCR Assay"}, {"text": "7. Set the thermal cycle conditions according to Table 3 . 8. Run the real-time RT-PCR under the conditions shown.", "cite_spans": [], "ref_spans": [{"start": 49, "end": 58, "text": "Table 3 .", "ref_id": null}], "section": "Real-Time RT-PCR Assay"}, {"text": "9. In the \"Edit Samples\" window, input the necessary information for the corresponding samples (e.g., name of the clinical specimen, positive and negative controls). Table 3 Conditions for the one-step real-time RT-PCR assay", "cite_spans": [], "ref_spans": [{"start": 166, "end": 173, "text": "Table 3", "ref_id": null}], "section": "Real-Time RT-PCR Assay"}, {"text": "Step Temperature (\u00b0C) Time 10. After performing the RT-PCR , examine the amplifi cation curves of the reactions and the corresponding threshold cycles (Ct). Positive clinical samples will generate amplifi cation curves above the threshold line, and negative samples and water control will be, by contrast, below the threshold line (Fig. 1a ) . Based on the Ct values from tenfold serial dilutions of a reference standard, the RT-PCR can be used to quantify the amount of input target in the positive samples by comparison with the reference (Fig. 1b ) . This amount can be automatically calculated by the software. 3. Primers and probe used in these assays are perfectly matched with the sequences deduced from the original ECoV-NC99 strain (EF446615) [ 13 ] .", "cite_spans": [{"start": 752, "end": 758, "text": "[ 13 ]", "ref_id": "BIBREF12"}], "ref_spans": [{"start": 331, "end": 341, "text": "(Fig. 1a )", "ref_id": "FIGREF2"}, {"start": 541, "end": 551, "text": "(Fig. 1b )", "ref_id": "FIGREF2"}], "section": "Real-Time RT-PCR Assay"}, {"text": "4. The RT-PCR has also been validated on the SmartCycler II \u00ae real-time PCR system (Cepheid \u00ae ) with the same RT-PCR thermal cycling conditions.", "cite_spans": [], "ref_spans": [], "section": "Real-Time RT-PCR Assay"}, {"text": "The \"M qRT-PCR \" should be tested with an internal quality control for viral diagnosis in order to exclude false negatives due to possible inhibition. 6 . A RNA transcript (10 5 copy/\u03bcl) deduced from M gene sequence of ECoV-NC99 strain has been used as positive control.", "cite_spans": [{"start": 151, "end": 152, "text": "6", "ref_id": "BIBREF5"}], "ref_spans": [], "section": "5."}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "Coronavirus diversity, phylogeny and interspecies jumping", "authors": [{"first": "P", "middle": ["C"], "last": "Woo", "suffix": ""}, {"first": "S", "middle": ["K"], "last": "Lau", "suffix": ""}, {"first": "Y", "middle": [], "last": "Huang", "suffix": ""}, {"first": "K", "middle": ["Y"], "last": "Yuen", "suffix": ""}], "year": 2009, "venue": "Exp Biol Med (Maywood)", "volume": "234", "issn": "10", "pages": "1117--1127", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "Characterization of a coronavirus isolated from a diarrheic foal", "authors": [{"first": "J", "middle": ["S"], "last": "Guy", "suffix": ""}, {"first": "J", "middle": ["J"], "last": "Breslin", "suffix": ""}, {"first": "B", "middle": [], "last": "Breuhaus", "suffix": ""}, {"first": "S", "middle": [], "last": "Vivrette", "suffix": ""}, {"first": "L", "middle": ["G"], "last": "Smith", "suffix": ""}], "year": 2000, "venue": "J Clin Microbiol", "volume": "38", "issn": "12", "pages": "4523--4526", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Isolation of an equine coronavirus from adult horses with pyrogenic and enteric disease and its antigenic and genomic characterization in comparison with the NC99 strain", "authors": [{"first": "Y", "middle": [], "last": "Oue", "suffix": ""}, {"first": "R", "middle": [], "last": "Ishihara", "suffix": ""}, {"first": "H", "middle": [], "last": "Edamatsu", "suffix": ""}, {"first": "Y", "middle": [], "last": "Morita", "suffix": ""}, {"first": "M", "middle": [], "last": "Yoshida", "suffix": ""}, {"first": "M", "middle": [], "last": "Yoshima", "suffix": ""}], "year": 2011, "venue": "Vet Microbiol", "volume": "150", "issn": "1-2", "pages": "41--48", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "Epidemic of equine coronavirus at Obihiro Racecourse, Hokkaido, Japan in 2012", "authors": [{"first": "Y", "middle": [], "last": "Oue", "suffix": ""}, {"first": "Y", "middle": [], "last": "Morita", "suffix": ""}, {"first": "T", "middle": [], "last": "Kondo", "suffix": ""}, {"first": "M", "middle": [], "last": "Nemoto", "suffix": ""}], "year": 2013, "venue": "J Vet Med Sci", "volume": "75", "issn": "9", "pages": "1261--1265", "other_ids": {}}, "BIBREF4": {"ref_id": "b4", "title": "Emerging outbreaks associated with equine coronavirus in adult horses", "authors": [{"first": "N", "middle": [], "last": "Pusterla", "suffix": ""}, {"first": "S", "middle": [], "last": "Mapes", "suffix": ""}, {"first": "C", "middle": [], "last": "Wademan", "suffix": ""}, {"first": "A", "middle": [], "last": "White", "suffix": ""}, {"first": "R", "middle": [], "last": "Ball", "suffix": ""}, {"first": "K", "middle": [], "last": "Sapp", "suffix": ""}], "year": 2013, "venue": "Vet Microbiol", "volume": "162", "issn": "1", "pages": "228--231", "other_ids": {}}, "BIBREF5": {"ref_id": "b5", "title": "First detection of equine coronavirus (ECoV) in Europe", "authors": [{"first": "F", "middle": [], "last": "Miszczak", "suffix": ""}, {"first": "V", "middle": [], "last": "Tesson", "suffix": ""}, {"first": "N", "middle": [], "last": "Kin", "suffix": ""}, {"first": "J", "middle": [], "last": "Dina", "suffix": ""}, {"first": "U", "middle": ["B"], "last": "Balasuriya", "suffix": ""}, {"first": "S", "middle": [], "last": "Pronost", "suffix": ""}], "year": 2014, "venue": "Vet Microbiol", "volume": "171", "issn": "1-2", "pages": "206--209", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "Prevalence of equine coronavirus in nasal secretions from horses with fever and upper respiratory tract infection", "authors": [{"first": "N", "middle": [], "last": "Pusterla", "suffix": ""}, {"first": "N", "middle": [], "last": "Holzenkaempfer", "suffix": ""}, {"first": "S", "middle": [], "last": "Mapes", "suffix": ""}, {"first": "P", "middle": [], "last": "Kass", "suffix": ""}], "year": 2015, "venue": "Vet Rec", "volume": "177", "issn": "", "pages": "", "other_ids": {}}, "BIBREF7": {"ref_id": "b7", "title": "Disease associated with equine coronavirus infection and high case fatality rate", "authors": [{"first": "C", "middle": ["L"], "last": "Fielding", "suffix": ""}, {"first": "J", "middle": ["K"], "last": "Higgins", "suffix": ""}, {"first": "J", "middle": ["C"], "last": "Higgins", "suffix": ""}, {"first": "S", "middle": [], "last": "Mcintosh", "suffix": ""}, {"first": "E", "middle": [], "last": "Scott", "suffix": ""}, {"first": "F", "middle": [], "last": "Giannitti", "suffix": ""}], "year": 2015, "venue": "J Vet Intern Med", "volume": "29", "issn": "1", "pages": "307--310", "other_ids": {}}, "BIBREF8": {"ref_id": "b8", "title": "Viral diarrhea", "authors": [{"first": "K", "middle": ["G"], "last": "Magdesian", "suffix": ""}, {"first": "R", "middle": ["M"], "last": "Dwyer", "suffix": ""}, {"first": "M", "middle": ["G"], "last": "Arguedas", "suffix": ""}], "year": 2014, "venue": "Equine infectious diseases", "volume": "", "issn": "", "pages": "198--203", "other_ids": {}}, "BIBREF9": {"ref_id": "b9", "title": "Rapid detection of equine coronavirus by reverse transcription loop-mediated isothermal amplifi cation", "authors": [{"first": "M", "middle": [], "last": "Nemoto", "suffix": ""}, {"first": "Y", "middle": [], "last": "Morita", "suffix": ""}, {"first": "H", "middle": [], "last": "Niwa", "suffix": ""}, {"first": "H", "middle": [], "last": "Bannai", "suffix": ""}, {"first": "K", "middle": [], "last": "Tsujimura", "suffix": ""}, {"first": "T", "middle": [], "last": "Yamanaka", "suffix": ""}], "year": 2015, "venue": "J Virol Methods", "volume": "", "issn": "", "pages": "13--19", "other_ids": {}}, "BIBREF10": {"ref_id": "b10", "title": "Neonatal enterocolitis associated with coronavirus infection in a foal: a case report", "authors": [{"first": "E", "middle": [], "last": "Davis", "suffix": ""}, {"first": "B", "middle": ["R"], "last": "Rush", "suffix": ""}, {"first": "J", "middle": [], "last": "Cox", "suffix": ""}, {"first": "B", "middle": [], "last": "Debey", "suffix": ""}, {"first": "S", "middle": [], "last": "Kapil", "suffix": ""}], "year": 2000, "venue": "J Vet Diagn Invest", "volume": "12", "issn": "2", "pages": "153--156", "other_ids": {}}, "BIBREF11": {"ref_id": "b11", "title": "Infectious agents associated with diarrhoea in neonatal foals in central Kentucky: a comprehensive molecular study", "authors": [{"first": "N", "middle": ["M"], "last": "Slovis", "suffix": ""}, {"first": "J", "middle": [], "last": "Elam", "suffix": ""}, {"first": "M", "middle": [], "last": "Estrada", "suffix": ""}, {"first": "C", "middle": ["M"], "last": "Leutenegger", "suffix": ""}], "year": 2013, "venue": "Equine Vet J", "volume": "46", "issn": "3", "pages": "311--316", "other_ids": {}}, "BIBREF12": {"ref_id": "b12", "title": "Genomic characterization of equine coronavirus", "authors": [{"first": "J", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "J", "middle": ["S"], "last": "Guy", "suffix": ""}, {"first": "E", "middle": ["J"], "last": "Snijder", "suffix": ""}, {"first": "D", "middle": ["A"], "last": "Denniston", "suffix": ""}, {"first": "P", "middle": ["J"], "last": "Timoney", "suffix": ""}, {"first": "U", "middle": ["B"], "last": "Balasuriya", "suffix": ""}], "year": 2007, "venue": "Virology", "volume": "369", "issn": "1", "pages": "92--104", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "\u03bcM PCR reverse primer (ECoV-M-r), 5\u2032-AGGTGCGAC ACCTTAGCAAC-3\u2032. 5. 10 \u03bcM PCR probe (ECoV-M-p), 5\u2032-(6FAM)-CCACAATAAT ACGTGGCCACCTTTA-(BHQ1)-3\u2032 ( see Note 3 ). strip tubes and caps (Qiagen \u00ae ).", "latex": null, "type": "figure"}, "FIGREF2": {"text": "Real-time RT-PCR assay for ECoV detection used as a quantitative RT-PCR (qRT-PCR ): partial M gene amplifi cation of tenfold serial dilution of RNA transcript from ECoV-NC99 strain. ( a ) Amplifi cation plot of normalized fl uorescence intensity versus number of PCR cycles. The X -axis represents the cycle number of the quantitative \"M qRT-PCR\" assay and the Y -axis, the normalized fl uorescence intensity. ( b ) Standard curve for quantitative analysis of ECoV. The threshold cycle (Ct) is the number of PCR cycles requires for the fl uorescent intensity of the reaction to predefi ne the threshold. The Ct is inversely proportional to the concentration of the input target (from 3 \u00d7 10 10 to 3 \u00d7 10 5 copy per ml). A linear quantitative detection range with a correlation coeffi cient ( R 2 ) of 0.997 was obtained with an effi ciency of 63 %4 Notes1. 1\u00d7 PBS buffer can be stored at room temperature for 6 months.2. Two other kits have also been used for RNA extraction from clinical fecal and respiratory samples: the High Pure RNA isolation Kit (Roche \u00ae ) with 200 \u03bcl of clinical sample and a 50 \u03bcl fi nal elution volume; and the Mag Attract Viral RNA M48 Kit (Qiagen \u00ae ), using the BioRobot M48 automated machine (Qiagen \u00ae ) with 300 \u03bcl of clinical sample and a 65 \u03bcl fi nal elution volume.", "latex": null, "type": "figure"}, "TABREF0": {"text": ". Materials 1. Autoclaved 1\u00d7 Phosphate Buffered Saline (PBS Buffer). For 1 l of 1\u00d7 PBS buffer, dissolve components as described inTable 1.", "latex": null, "type": "table"}, "TABREF1": {"text": "", "latex": null, "type": "table"}, "TABREF3": {"text": "Components of one-step real-time RT-PCR assay", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td> Volume per reaction (\u03bcl) </td><td> Volume mix for N reactions a (\u03bcl) </td><td> Final </td></tr><tr><td> Reagent </td><td>\u00a0</td><td>\u00a0</td><td>concentration </td></tr><tr><td> 2\u00d7 Reaction Mix </td><td> 12.5 </td><td> 12.5 \u00d7 N </td><td> 1\u00d7 </td></tr><tr><td> MgSO 4 (50 mM) </td><td> 1.5 </td><td> 1.5 \u00d7 N </td><td> 3.0 mM </td></tr><tr><td> forward primer (ECoV-M-f) (10 \u03bcM) </td><td> 1.5 </td><td> 1.5 \u00d7 N </td><td> 0.6 \u03bcM </td></tr><tr><td> PCR reverse primer (ECoV-M-r) (10 \u03bcM) </td><td> 1.5 </td><td> 1.5 \u00d7 N </td><td> 0.6 \u03bcM </td></tr><tr><td> PCR probe (ECoV-M-p) (10 \u03bcM) </td><td> 0.5 </td><td> 0.5 \u00d7 N </td><td> 0.2 \u03bcM </td></tr><tr><td> Superscript \u00ae III RT/Platinum Taq \u00ae Mix </td><td> 0.5 </td><td> 0.5 \u00d7 N </td><td> - </td></tr><tr><td> Autoclaved RNase-free water or equivalent </td><td> 2 </td><td> 2 \u00d7 N </td><td> - </td></tr><tr><td> Total </td><td> 20 </td><td> 20 \u00d7 N </td><td> - </td></tr></table></body></html>"}}, "back_matter": [{"text": "We acknowledge French equine practitioners and the LABEO Frank Duncombe Laboratory for providing fecal and respiratory samples needful to develop this real-time RT-PCR .", "cite_spans": [], "ref_spans": [], "section": "Acknowledgments"}]}